Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.78 million shares were traded. CTOR stock price reached its highest trading level at $1.2076 during the session, while it also had its lowest trading level at $1.07.
Ratios:
We take a closer look at CTOR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.02 and its Current Ratio is at 0.35. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.12.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTOR now has a Market Capitalization of 94370184 and an Enterprise Value of 92358760.
Stock Price History:
The Beta on a monthly basis for CTOR is 3.21, which has changed by 0.32941175 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, CTOR has reached a high of $6.19, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -32.25%, while the 200-Day Moving Average is calculated to be -26.31%.
Shares Statistics:
According to the various share statistics, CTOR traded on average about 228.56K shares per day over the past 3-months and 312560 shares per day over the past 10 days. A total of 71.55M shares are outstanding, with a floating share count of 9.36M. Insiders hold about 88.79% of the company’s shares, while institutions hold 9.99% stake in the company. Shares short for CTOR as of 1761868800 were 251359 with a Short Ratio of 1.10, compared to 1759190400 on 169028. Therefore, it implies a Short% of Shares Outstanding of 251359 and a Short% of Float of 1.4400001.
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate. The current performance of Citius Oncology Inc (CTOR) in the stock market.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.33 and -$0.33 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.14, with 1.0 analysts recommending between -$0.14 and -$0.14.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $4.37M. There is a high estimate of $4.37M for the next quarter, whereas the lowest estimate is $4.37M. Based on 1 analysts’ estimates, the company’s revenue will be $62.47M in the next fiscal year. The high estimate is $62.47M and the low estimate is $62.47M.
